PK/PD considerations when treating MRSA
Author(s) -
Teresita Mazzei
Publication year - 2012
Publication title -
international journal of infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2012.05.135
Subject(s) - teicoplanin , pharmacokinetics , medicine , linezolid , pharmacodynamics , vancomycin , antibiotics , cmax , pharmacology , dose , antimicrobial , minimum inhibitory concentration , drug , therapeutic drug monitoring , sepsis , intensive care medicine , staphylococcus aureus , chemistry , biology , biochemistry , organic chemistry , bacteria , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom